Skip to main content
Fig. 2 | Trials

Fig. 2

From: Single-dose versus 3-day cotrimoxazole prophylaxis in transurethral resection or greenlight laser vaporisation of the prostate: study protocol for a multicentre randomised placebo controlled non-inferiority trial (CITrUS trial)

Fig. 2

Study procedures and assessments. AP antimicrobial prophylaxis, ASA American Society of Anaesthesiologists, BMI body mass index, cfu colony forming units, DDD defined daily doses, ID identification (number), ICU intensive care unit, MRGN multi-resistant Gram-negatives, PSA prostate specific antigen, UTI urinary tract infection. *Between hospital discharge and close-out visit

Back to article page